| Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes | Hepatology | 2016 | 4.3K |
| AASLD guidelines for treatment of chronic hepatitis B | Hepatology | 2016 | 1.3K |
| Bowel Disorders | Gastroenterology | 2016 | 1.3K |
| Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism | Gut Microbes | 2016 | 1.2K |
| The gut microbiota and host health: a new clinical frontier | Gut | 2016 | 1.2K |
| Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma | Gastroenterology | 2016 | 1K |
| Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV | Gastroenterology | 2016 | 939 |
| Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology | Gut | 2016 | 938 |
| ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus | American Journal of Gastroenterology | 2016 | 928 |
| Gastroduodenal Disorders | Gastroenterology | 2016 | 746 |
| High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome | Gut | 2016 | 711 |
| Immunopathogenesis of IBD: current state of the art | Nature Reviews Gastroenterology and Hepatology | 2016 | 708 |
| Epidemiology of pancreatic cancer | World Journal of Gastroenterology | 2016 | 679 |
| Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells | Hepatology | 2016 | 676 |
| The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota | Hepatology | 2016 | 655 |
| Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening | Gastroenterology | 2016 | 629 |
| Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) | Nature Reviews Gastroenterology and Hepatology | 2016 | 618 |
| Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction | Gastroenterology | 2016 | 598 |
| Functional Disorders: Children and Adolescents | Gastroenterology | 2016 | 580 |
| Proton pump inhibitors affect the gut microbiome | Gut | 2016 | 575 |
| The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe | Hepatology | 2016 | 569 |
| Immunology in the liver--from homeostasis to disease | Nature Reviews Gastroenterology and Hepatology | 2016 | 514 |
| Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates | Gut | 2016 | 488 |
| Diet, microorganisms and their metabolites, and colon cancer | Nature Reviews Gastroenterology and Hepatology | 2016 | 478 |
| Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes | World Journal of Gastroenterology | 2016 | 459 |
